Trademark: 79234854
Word
INNOVENT
Status
Registered
Status Code
700
Status Date
Tuesday, March 24, 2020
Serial Number
79234854
Registration Number
6015574
Registration Date
Tuesday, March 24, 2020
Mark Type
3000
Filing Date
Monday, April 16, 2018
Published for Opposition
Tuesday, January 7, 2020

Trademark Owner History

Classifications
5 Medicines for human purposes, namely, antibody preparations, protein preparations, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Pharmaceutical preparations, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Vaccines; drugs for medical purposes, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Biological preparations for medical purposes, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Diagnostic preparations for medical purposes; Biological tissue cultures for medical purposes; Chemical reagents for medical purposes; all of the aforesaid excluding goods in gaseous form, goods related to nitric oxide, and veterinary products, preparations, reagents, and medicine for animal health
Color is not claimed as a feature of the mark.
The trademark consists of the English letters of "I", "N", "N", "O", "V", "E", "N" and "T", in which the English letter "O" is designed by two symmetrical arcs. The mark has no particular meaning when taken as a whole.

Trademark Events
Jul 31, 2020
Final Decision Transaction Processed By Ib
Jul 10, 2020
Final Disposition Notice Sent To Ib
Jul 10, 2020
Final Disposition Processed
Jun 25, 2020
New Representative At Ib Received
Jun 25, 2020
New Representative At Ib Received
Jun 24, 2020
Final Disposition Notice Created, To Be Sent To Ib
Mar 24, 2020
Registered-Principal Register
Jan 7, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 7, 2020
Published For Opposition
Jan 3, 2020
Notification Processed By Ib
Dec 18, 2019
Notification Of Possible Opposition Sent To Ib
Dec 18, 2019
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 18, 2019
Notification Of Notice Of Publication E-Mailed
Dec 13, 2019
Notification Of Possible Opposition - Processed By Ib
Dec 4, 2019
Approved For Pub - Principal Register
Dec 4, 2019
Examiner's Amendment Entered
Dec 4, 2019
Notification Of Examiners Amendment E-Mailed
Dec 4, 2019
Examiners Amendment E-Mailed
Dec 4, 2019
Examiners Amendment -Written
Nov 27, 2019
Notification Of Possible Opposition Sent To Ib
Nov 27, 2019
Notification Of Possible Opposition Created, To Be Sent To Ib
Nov 18, 2019
Teas/Email Correspondence Entered
Nov 18, 2019
Correspondence Received In Law Office
Nov 18, 2019
Teas Response To Office Action Received
Nov 18, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 18, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 29, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 29, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 28, 2019
Notification Of Notice Of Unresponsive Amendment - E-Mailed
Oct 28, 2019
Notice Of Unresponsive Amendment - E-Mailed
Oct 28, 2019
Report Unresponsive Amendment - Completed
Oct 26, 2019
Teas/Email Correspondence Entered
Oct 25, 2019
Correspondence Received In Law Office
Oct 25, 2019
Teas Request For Reconsideration Received
Oct 25, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 25, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 13, 2019
Notification Of Final Refusal Emailed
Aug 13, 2019
Final Refusal E-Mailed
Aug 13, 2019
Final Refusal Written
Jul 16, 2019
Lie Checked Susp - To Atty For Action
Jan 18, 2019
Limitation From The Ib - Request Exam Review
Dec 12, 2018
Data Modification Completed
Dec 11, 2018
Notification Of Letter Of Suspension E-Mailed
Dec 11, 2018
Letter Of Suspension E-Mailed
Dec 11, 2018
Suspension Letter Written
Dec 7, 2018
Limitation Of Goods Received From Ib
Nov 26, 2018
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 26, 2018
Data Modification Completed
Nov 21, 2018
Assigned To Lie
Nov 19, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 19, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 19, 2018
Teas/Email Correspondence Entered
Nov 19, 2018
Correspondence Received In Law Office
Nov 19, 2018
Teas Response To Office Action Received
Sep 7, 2018
Refusal Processed By Ib
Aug 20, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Aug 20, 2018
Refusal Processed By Mpu
Aug 4, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Aug 3, 2018
Non-Final Action Written
Aug 3, 2018
Assigned To Examiner
Jul 6, 2018
Application Filing Receipt Mailed
Jul 2, 2018
New Application Office Supplied Data Entered In Tram
Jun 25, 2018
Limitation From Original Application Entered
Jun 21, 2018
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24